The triterpenoid CDDO-imidazolide reduces immune cell infiltration and cytokine secretion in the KrasG12D;Pdx1-Cre (KC) mouse model of pancreatic cancer
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The triterpenoid CDDO-imidazolide reduces immune cell infiltration and cytokine secretion in the KrasG12D;Pdx1-Cre (KC) mouse model of pancreatic cancer
Authors
Keywords
-
Journal
CARCINOGENESIS
Volume -, Issue -, Pages bgw099
Publisher
Oxford University Press (OUP)
Online
2016-09-23
DOI
10.1093/carcin/bgw099
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- CDDO-Me Redirects Activation of Breast Tumor Associated Macrophages
- (2016) Michael S. Ball et al. PLoS One
- Cancer statistics, 2015
- (2015) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Dimethyl fumarate and the oleanane triterpenoids, CDDO-imidazolide and CDDO-methyl ester, both activate the Nrf2 pathway but have opposite effects in the A/J model of lung carcinogenesis
- (2015) Ciric To et al. CARCINOGENESIS
- Inflammation and cancer: advances and new agents
- (2015) Shanthini M. Crusz et al. Nature Reviews Clinical Oncology
- Novel synthetic pyridyl analogues of CDDO-Imidazolide are useful new tools in cancer prevention
- (2015) Martine Cao et al. PHARMACOLOGICAL RESEARCH
- Targeting pancreatitis blocks tumor-initiating stem cells and pancreatic cancer progression
- (2015) Altaf Mohammed et al. Oncotarget
- RTA 408, A Novel Synthetic Triterpenoid with Broad Anticancer and Anti-Inflammatory Activity
- (2015) Brandon L. Probst et al. PLoS One
- Cancer Immunoprevention--The Next Frontier
- (2014) M.-A. D. Smit et al. Cancer Prevention Research
- CSF1/CSF1R Blockade Reprograms Tumor-Infiltrating Macrophages and Improves Response to T-cell Checkpoint Immunotherapy in Pancreatic Cancer Models
- (2014) Y. Zhu et al. CANCER RESEARCH
- Gemcitabine: Metabolism and molecular mechanisms of action, sensitivity and chemoresistance in pancreatic cancer
- (2014) Lucas de Sousa Cavalcante et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Interleukin-6: a villain in the drama of pancreatic cancer development and progression
- (2014) Reinhild Holmer et al. Hepatobiliary & Pancreatic Diseases International
- The therapeutic value of targeting inflammation in gastrointestinal cancers
- (2014) Beicheng Sun et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- nab-Paclitaxel: Novel Clinical and Experimental Evidence in Pancreatic Cancer
- (2014) A. Neesse et al. ZEITSCHRIFT FUR GASTROENTEROLOGIE
- Impact of tumour associated macrophages in pancreatic cancer
- (2013) Ainhoa Mielgo et al. BMB Reports
- Dimethylaminoparthenolide and gemcitabine: a survival study using a genetically engineered mouse model of pancreatic cancer
- (2013) Michele T Yip-Schneider et al. BMC CANCER
- Interleukin-6 Is Required for Pancreatic Cancer Progression by Promoting MAPK Signaling Activation and Oxidative Stress Resistance
- (2013) Y. Zhang et al. CANCER RESEARCH
- Prolonged survival and delayed progression of pancreatic intraepithelial neoplasia in LSL-KrasG12D/+;Pdx-1-Cre mice by vitamin E -tocotrienol
- (2013) K. Husain et al. CARCINOGENESIS
- Role of bacterial infections in pancreatic cancer
- (2013) D. S. Michaud CARCINOGENESIS
- Inflammatory Monocyte Mobilization Decreases Patient Survival in Pancreatic Cancer: A Role for Targeting the CCL2/CCR2 Axis
- (2013) D. E. Sanford et al. CLINICAL CANCER RESEARCH
- Inflammatory networks and immune surveillance of pancreatic carcinoma
- (2013) Robert H Vonderheide et al. CURRENT OPINION IN IMMUNOLOGY
- A Starring Role for Stellate Cells in the Pancreatic Cancer Microenvironment
- (2013) Minoti V. Apte et al. GASTROENTEROLOGY
- Role of Immune Cells and Immune-Based Therapies in Pancreatitis and Pancreatic Ductal Adenocarcinoma
- (2013) Lei Zheng et al. GASTROENTEROLOGY
- The Epidemiology of Pancreatitis and Pancreatic Cancer
- (2013) Dhiraj Yadav et al. GASTROENTEROLOGY
- Recapitulating human cancer in a mouse
- (2013) Lynda Chin et al. NATURE BIOTECHNOLOGY
- Oncogenic RAS pathway activation promotes resistance to anti-VEGF therapy through G-CSF-induced neutrophil recruitment
- (2013) V. T. Phan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Clinical Perspectives on Targeting of Myeloid Derived Suppressor Cells in the Treatment of Cancer
- (2013) Yana G. Najjar et al. Frontiers in Oncology
- Tumor-Derived Granulocyte-Macrophage Colony-Stimulating Factor Regulates Myeloid Inflammation and T Cell Immunity in Pancreatic Cancer
- (2012) Lauren J. Bayne et al. CANCER CELL
- Oncogenic Kras-Induced GM-CSF Production Promotes the Development of Pancreatic Neoplasia
- (2012) Yuliya Pylayeva-Gupta et al. CANCER CELL
- The Synthetic Triterpenoid CDDO-Methyl Ester Delays Estrogen Receptor-Negative Mammary Carcinogenesis in Polyoma Middle T Mice
- (2012) K. Tran et al. Cancer Prevention Research
- An NF-κB pathway–mediated positive feedback loop amplifies Ras activity to pathological levels in mice
- (2012) Jaroslaw Daniluk et al. JOURNAL OF CLINICAL INVESTIGATION
- Targeted Therapeutic Remodeling of the Tumor Microenvironment Improves an HER-2 DNA Vaccine and Prevents Recurrence in a Murine Breast Cancer Model
- (2011) D. Liao et al. CANCER RESEARCH
- Perspective: The big C — for Chemoprevention
- (2011) Michael B. Sporn NATURE
- FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
- (2011) Thierry Conroy et al. NEW ENGLAND JOURNAL OF MEDICINE
- Deficiency of the macrophage growth factor CSF-1 disrupts pancreatic neuroendocrine tumor development
- (2011) S M Pyonteck et al. ONCOGENE
- Synthetic Triterpenoids Prolong Survival in a Transgenic Mouse Model of Pancreatic Cancer
- (2010) K. T. Liby et al. Cancer Prevention Research
- Anti-inflammatory Triterpenoid Blocks Immune Suppressive Function of MDSCs and Improves Immune Response in Cancer
- (2010) S. Nagaraj et al. CLINICAL CANCER RESEARCH
- The Synthetic Triterpenoid, CDDO-Me, Modulates the Proinflammatory Response to In Vivo Lipopolysaccharide Challenge
- (2010) Jeffery J. Auletta et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- Acute pancreatitis markedly accelerates pancreatic cancer progression in mice expressing oncogenic Kras
- (2009) Catherine Carrière et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- K-RASmutation in the screening, prognosis and treatment of cancer
- (2009) Barbara L Parsons et al. Biomarkers in Medicine
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now